Kanof P D, Aronson M J, Ness R
Psychiatry Service, VA Medical Center, Bronx, N.Y.
Am J Psychiatry. 1993 Mar;150(3):423-8. doi: 10.1176/ajp.150.3.423.
The authors delineate the clinical characteristics of mood state changes that occur in stable opioid-dependent patients undergoing therapeutic detoxification from methadone maintenance treatment.
Twenty-four patients participated in a blinded protocol for gradual methadone dose reduction that included weekly assessments of affective state using the Profile of Mood States (POMS) as well as weekly assessments of signs and symptoms of opioid withdrawal. Data obtained before methadone dose reduction and during the 2-week period of maximal dysphoric symptoms were compared. Changes in affective and opioid withdrawal measures were compared in patients who differed in their success in completing the detoxification regimen.
Sustained increases in POMS scores of greater than 20 points were observed in 12 of the 24 patients during the course of detoxification. The emergence of symptoms of dysphoria was accompanied by insomnia, loss of appetite, and somatic complaints consistent with symptoms of opioid withdrawal but only minimal levels of objective signs of withdrawal. Greater changes from baseline in mood state and opioid withdrawal measures occurred in patients who were unable to complete the detoxification regimen.
The development of an organic mood syndrome is a common occurrence in patients undergoing slow detoxification from methadone maintenance treatment and is associated with a poor outcome.
作者阐述了正在接受美沙酮维持治疗的稳定阿片类药物依赖患者在进行治疗性脱毒时出现的情绪状态变化的临床特征。
24名患者参与了一项美沙酮剂量逐渐减少的盲法方案,其中包括使用情绪状态量表(POMS)每周评估情感状态以及每周评估阿片类药物戒断的体征和症状。比较了美沙酮剂量减少前和出现最大烦躁症状的2周期间获得的数据。对完成脱毒方案成功程度不同的患者的情感和阿片类药物戒断指标变化进行了比较。
在脱毒过程中,24名患者中有12名患者的POMS评分持续增加超过20分。烦躁症状的出现伴有失眠、食欲不振和与阿片类药物戒断症状一致的躯体不适,但仅有最低水平的客观戒断体征。无法完成脱毒方案的患者的情绪状态和阿片类药物戒断指标与基线相比变化更大。
在从美沙酮维持治疗缓慢脱毒的患者中,器质性情绪综合征的发生很常见,且与不良预后相关。